| Announce Date | 08/14/2025 | 
| EPS Normalized Actual | $0.69 (Beat by $0.1) | 
| EPS GAAP Actual | $0.69 (Beat by $0.1) | 
| Revenue Actual | $2.01B | 
| Revenue Surprise | Beat by $2010M | 
| Announce Date | 12/31/1969 (Pre-Market) | 
| EPS Normalized Estimate | $ | 
| EPS GAAP Estimate | $ | 
| Revenue Estimate | $0B | 
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts | 
|---|---|---|---|---|---|
| Dec 2029 | 7.57 | 6.69 | 7.3981 | 7.69944 | 4 | 
| Dec 2029 | 0 | INF | 0 | 0 | 4 | 
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss | 
|---|---|---|---|---|---|
| FQ3 2025 (Jul 2025) | 0.25 | 0.25 | 2.01B | -33.49% | 2010M | 
| FQ2 2025 (Apr 2025) | 0 | 0 | 0B | -INF% | 0M | 
| FQ4 2024 (Oct 2024) | -0.42 | -0.42 | 2.14799B | -14.75% | 2147.99M | 
| FQ3 2024 (Jul 2024) | 0.75 | 0.75 | 2.68305B | -0.11% | 2683.05M | 
| FQ2 2024 (Apr 2024) | 0.67 | 0.67 | 3.40625B | 100% | 3406.25M | 
| FQ4 2023 (Dec 2023) | -0.59 | -0.59 | 2.46487B | -7.16% | 2464.87M | 
| FQ3 2023 (Jul 2023) | 1.44 | 1.44 | 2.68607B | 100% | 2686.07M | 
| FQ2 2023 (Apr 2023) | 0 | 0 | 0B | NAN% | 0M | 
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts | 
|---|---|---|---|---|---|
| FQ3 2027 (Jul 2027) | 1.22 | -- | 1.15417 | 1.25498 | 11 | 
| FQ2 2027 (Apr 2027) | 1.48 | -- | 1.40014 | 1.52244 | 11 | 
| FQ1 2027 (Jan 2027) | 0.157 | -- | 0.14583 | 0.16566 | 4 | 
| FQ4 2026 (Oct 2026) | 1.11668 | -- | 1.08297 | 1.14604 | 1 | 
| FQ3 2026 (Jul 2026) | 0.72565 | 65.55 | 0.69249 | 0.753 | 9 | 
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts | 
|---|---|---|---|---|---|
| FQ3 2027 (Jul 2027) | 1.92B | -- | 1.84B | 1.97B | 12 | 
| FQ2 2027 (Apr 2027) | 1.94B | -- | 1.85B | 1.98B | 12 | 
| FQ1 2027 (Jan 2027) | 1.88B | -- | 1.78B | 1.96B | 7 | 
| FQ4 2026 (Oct 2026) | 2.57B | -- | 2.51B | 2.62B | 2 | 
| FQ3 2026 (Jul 2026) | 1.95B | -3.03 | 1.88B | 2.01B | 7 | 
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts | 
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 | 
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 | 
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 | 
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 | 
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts | 
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 | 
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 | 
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 | 
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 | 
EPS # of Beats
4
EPS # of Misses
2
EPS # of in-lines
2
Revenue # of Beats
6
Revenue # of Misses
0
Revenue # of in-lines
2
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % | 
|---|---|---|---|---|
| FQ3 2025 (Jul 2025) | 0.25 | 0.25 | 100% | |
| FQ2 2025 (Apr 2025) | 0 | 0 | NAN% | |
| FQ4 2024 (Oct 2024) | -0.42 | -0.42 | 100% | |
| FQ3 2024 (Jul 2024) | 0.75 | 0.75 | 100% | |
| FQ2 2024 (Apr 2024) | 0.67 | 0.67 | 100% | |
| FQ4 2023 (Dec 2023) | -0.59 | -0.59 | 100% | |
| FQ3 2023 (Jul 2023) | 1.44 | 1.44 | 100% | |
| FQ2 2023 (Apr 2023) | 0 | 0 | NAN% | 
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % | 
|---|---|---|---|---|
| FQ3 2025 (Jul 2025) | $0B | $2.01B | $2010M | 100% | 
| FQ2 2025 (Apr 2025) | $0B | $0B | $0M | NAN% | 
| FQ4 2024 (Oct 2024) | $0B | $2.15B | $2147.99M | 100% | 
| FQ3 2024 (Jul 2024) | $0B | $2.68B | $2683.05M | 100% | 
| FQ2 2024 (Apr 2024) | $0B | $3.41B | $3406.25M | 100% | 
| FQ4 2023 (Dec 2023) | $0B | $2.46B | $2464.87M | 100% | 
| FQ3 2023 (Jul 2023) | $0B | $2.69B | $2686.07M | 100% | 
| FQ2 2023 (Apr 2023) | $0B | $0B | $0M | NAN% |